Netris Pharma Orano and CLB ink scientific collaboration to develop novel antibody radio conjugate therapies
By, Admin1 min read
Share
Netris Pharma SAS, a private clinical-stage biopharmaceutical company, announced that it has entered into a scientific collaboration agreement with Orano and the Centre Le
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
